Investment
Features
FeesSafety
Academy
More
Pluang+

Compare IKA (IKA) vs Enzyme (MLN) Price & Performance

Price performance (Past 24H)

Key statistics

IKA vs Enzyme — how do they compare? IKA trades at Rp46.62 (market cap Rp139,94M, Rp4,81M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: IKA and Enzyme are close in size by market cap, and IKA's circulating supply is 3B IKA versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold IKA for 3 Days and Enzyme for 29 Days on average.

IKAMLN
Market Cap
Rp139,94MRp134,13M
Volume (24h)
Rp4,81MRp104,56M
Circulating Supply
3B IKA3,3M MLN
Typical Hold Time
3 Days29 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

IKA

IKA trades at Rp46.73 with a market cap of Rp141.55M, showing neutral technical signals across moving averages and oscillators. The token currently sits between support at Rp43 and resistance at Rp49, indicating consolidation. With a short average hold time of 3 days, traders appear to be taking quick positions rather than long-term holding. No recent protocol updates or ecosystem developments have been reported for this digital asset.

Overall outlook remains neutral with limited trading activity and minimal fundamental catalysts. Key opportunities include potential breakout above Rp49 resistance, while major risks include low liquidity and the token's small market cap making it vulnerable to volatility. Investors should monitor for any upcoming protocol developments or exchange listings that could drive momentum.

Enzyme

Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.

Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IKA
61% Buy39% Sell
Avg holding period · 3 Days
MLN

No sentiment data available yet.

About IKA

Ika is a decentralized network enabling secure, native cross-chain interoperability through advanced cryptography. It allows smart contracts to manage assets across multiple blockchains without relying on bridges or wrapped tokens. Using 2PC-MPC cryptography, Ika provides zero-trust asset control across chains like Bitcoin and Ethereum. Its dWallet primitive enables programmable, consent-based signing, and it is built on Sui for high-speed, scalable transactions.

Read more on IKA

About Enzyme

Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.

Read more on MLN